Di Martino L, Tarquini A, Mitchell I, Deshpande N
Tumori. 1980 Apr 30;66(2):197-203. doi: 10.1177/030089168006600208.
The ability of human breast carcinomas to convert pregnenolone to progesterone and dehydroepiandrosterone to delta 4-androstene-3,17-dione (delta 4) was investigated as a potential aid for prognosis, and the following observations were recorded. 1. Neither the amounts of progesterone or delta 4 synthesized nor delta 4/progesterone ratios correlated with tumour size or lymph node involvement. 2. delta 4 synthesis was lower in carcinomas from patients who had recurrences within 2 years of mastectomy than in carcinomas from those who remained free of metastases. 3. Life table analysis of the results indicated that these parameters appeared unlikely to be useful aids for prognosis.
研究了人类乳腺癌将孕烯醇酮转化为孕酮以及将脱氢表雄酮转化为Δ4-雄烯-3,17-二酮(Δ4)的能力,以此作为一种潜在的预后辅助指标,并记录了以下观察结果。1. 合成的孕酮或Δ4的量以及Δ4/孕酮比值均与肿瘤大小或淋巴结受累情况无关。2. 乳房切除术后2年内复发患者的癌组织中Δ4合成量低于无转移患者的癌组织。3. 对结果进行的生命表分析表明,这些参数似乎不太可能作为有用的预后辅助指标。